Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Citations
4,408 citations
318 citations
11 citations
10 citations
7 citations
References
36,578 citations
"Designing therapeutic strategies to..." refers background in this paper
...Tumor necrosis factor-α a key player in immune activation and inflammation principally released from activated macrophages is found elevated in critically ill COVID-19 patients (Huang et al., 2020)....
[...]
...…may also develop acute respiratory distress syndrome (ARDS), respiratory failure, acute cardiac injury, coagulation abnormalities, disturbed immune system causing amplified cytokines release, and multiple organ failure resulting in death (Chen et al., 2020; Huang et al., 2020; Wang et al., 2020)....
[...]
...…antibody Tumor necrosis factor (TNF) α inhibition Inhibits tumor necrosis factor (TNF) α and prevent TNF dependent cytokine cascade and tissue damage Huang et al. (2020) Recombinant human soluble ACE2 (rhACE2) RAS modifier ACE2 enhancement Restore renin angiotensin system…...
[...]
...Extensive laboratory test findings comprise higher leucocyte count, increased erythrocyte sedimentation rate (ESR), elevated C-reactine protein (CRP), creatinine kinase, lactate dehydrogenase, increased thrombogenic biomarkers D-dimer, and prolonged prothrombin time (Huang et al., 2020)....
[...]
...Ground-glass opacification with or without consolidative abnormalities is revealed as hallmark of COVID-19 infection in Chest computed tomography (CT) (Huang et al., 2020)....
[...]
20,189 citations
16,857 citations
"Designing therapeutic strategies to..." refers background or methods in this paper
...Several independent retrospective studies have assessed the risk factors associated with disease severity and stipulated older population with immune-compromised/co-morbid conditions as more vulnerable targets (Wang et al., 2020; Zhou et al., 2020a, b)....
[...]
...…utilize the same entry portal as used by SARS-CoV (severe acute respiratory syndrome coronavirus), type 1 transmembrane angiotensin-converting enzyme 2 (ACE2) receptor to enter the host cell through fusion between viral and cellular membrane assisted by host cell proteases (Zhou et al., 2020a, b)....
[...]
16,635 citations
"Designing therapeutic strategies to..." refers background in this paper
...Several independent retrospective studies have assessed the risk factors associated with disease severity and stipulated older population with immune-compromised/co-morbid conditions as more vulnerable targets (Wang et al., 2020; Zhou et al., 2020a, b)....
[...]
...…may also develop acute respiratory distress syndrome (ARDS), respiratory failure, acute cardiac injury, coagulation abnormalities, disturbed immune system causing amplified cytokines release, and multiple organ failure resulting in death (Chen et al., 2020; Huang et al., 2020; Wang et al., 2020)....
[...]
...Email: rh.suman@gmail.com A highly contagious coronavirus disease COVID-19 caused by a recently identified severe acute respiratory syndrome CoV-2 (SARS-CoV-2) initially detected in Wuhan, China has spread worldwide and become a major health crisis in the absence of spe- cific vaccine or antiviral drugs....
[...]
...COVID 19 is a highly contagious respiratory tract infection caused by recently identified severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) originated from Wuhan, China (Wang et al., 2020)....
[...]
...Recently remdesvir revealed inhibitory effects (EC90 of 1.76 μM) against SARS-CoV-2 in an in vitro cell culture study (Wang et al., 2020)....
[...]
16,282 citations